Loading stock data…
AMP
$468.59+3.10 (+0.67%)
Pre-Market$472.34+3.75 (+0.80%)· Last close May 4
Ameriprise Financial, Inc., together with its subsidiaries, operates as a diversified financial services company in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Ameriprise Financial, Inc. in the Financial Services sector is trading at $468.59. The stock is currently 15% below its 52-week high of $550.18, remaining 2.3% below its 200-day moving average. Technical signals show neutral RSI of 56 and bullish MACD crossover, explaining why AMP maintains its current current market pressure. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 56) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$468.59
Potential Upside
115.5%
Whystock Fair Value$1009.97
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus11 analysts
Buy
Mean target$539.82+15.2%
Range$460.00 – $636.00
Fundamentals
Ameriprise Financial, Inc., together with its subsidiaries, operates as a diversified financial services company in the United States and internationally. The company offers financial planning and advice services to individual and institutional clien...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$43.53B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.92
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.27
Div Yield
Strong income play. Yield provides a meaningful total return floor.
137.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
49.24%
Volume
Today's trading volume
322,393
Recent News
Ameriprise Financial touts record 2025 results at annual meeting; shareholders back all proposals
Ameriprise Financial (NYSE:AMP) used its 2026 annual meeting of shareholders to highlight record results in 2025, describe what CEO Jim Cracchiolo characterized as a “dynamic and fast-paced” operating environment, and outline continued investments in advice, technology and product capabilities to su
Ameriprise Financial (NYSE:AMP) Could Be A Buy For Its Upcoming Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Massachusetts Says Fidelity Was Lax With Customer Data. Now the Firm Must Pay $1.25 Million.
Massachusetts regulators alleged that Fidelity’s failure to adhere to its security protocols compromised sensitive information from 77,000 individuals.
Ares Management Q1 Earnings on the Deck: Here's What to Expect
ARES's Q1 results, scheduled to report on May 1, are likely to reflect strong Y/Y revenue and earnings growth. However, rising expenses may weigh on earnings.
Is Ameriprise Financial (AMP) Still Attractive After Doubling Over The Past Five Years
Wondering whether Ameriprise Financial is attractively priced at its current level, or if most of the upside is already on the table? This article focuses squarely on what you are paying versus what you might be getting. The stock last closed at US$464.12, with returns of 1.7% over the past week, 6.3% over the last month, 0.9% over the past year and 93.6% over five years. The year-to-date return sits at a 6.0% decline, and the three-year return is 58.6%. Recent coverage of Ameriprise...